Stem definition | Drug id | CAS RN |
---|---|---|
845 | 492-61-5 |
None
Property | Value | Reference |
---|---|---|
BA (Bioavailability) | 99 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Date | Agency | Company | Orphan |
---|---|---|---|
Jan. 17, 1946 | FDA | B BRAUN |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Peritonitis bacterial | 2226.68 | 9.79 | 856 | 134403 | 8649 | 53205158 |
Death | 1904.43 | 9.79 | 3308 | 131951 | 353924 | 52859883 |
Peritonitis | 1623.20 | 9.79 | 882 | 134377 | 20805 | 53193002 |
Fluid overload | 912.18 | 9.79 | 671 | 134588 | 27160 | 53186647 |
Peritoneal dialysis complication | 845.85 | 9.79 | 305 | 134954 | 2528 | 53211279 |
Drug ineffective | 522.52 | 9.79 | 794 | 134465 | 816451 | 52397356 |
Rheumatoid arthritis | 489.55 | 9.79 | 101 | 135158 | 314430 | 52899377 |
Sepsis | 280.91 | 9.79 | 913 | 134346 | 145516 | 53068291 |
Bloody peritoneal effluent | 278.82 | 9.79 | 86 | 135173 | 409 | 53213398 |
Cardiac failure congestive | 262.10 | 9.79 | 665 | 134594 | 92092 | 53121715 |
Hypokalaemia | 245.18 | 9.79 | 665 | 134594 | 95852 | 53117955 |
Myelosuppression | 244.78 | 9.79 | 226 | 135033 | 12602 | 53201205 |
Ultrafiltration failure | 230.95 | 9.79 | 80 | 135179 | 581 | 53213226 |
Fungal peritonitis | 227.14 | 9.79 | 86 | 135173 | 828 | 53212979 |
Joint swelling | 222.86 | 9.79 | 162 | 135097 | 234476 | 52979331 |
Contraindicated product administered | 207.69 | 9.79 | 45 | 135214 | 135584 | 53078223 |
Hypotension | 195.63 | 9.79 | 1206 | 134053 | 252870 | 52960937 |
Hand deformity | 195.35 | 9.79 | 4 | 135255 | 84845 | 53128962 |
Dehydration | 195.17 | 9.79 | 895 | 134364 | 167515 | 53046292 |
Alopecia | 185.14 | 9.79 | 193 | 135066 | 234390 | 52979417 |
Systemic lupus erythematosus | 177.60 | 9.79 | 49 | 135210 | 125365 | 53088442 |
Arthropathy | 168.15 | 9.79 | 74 | 135185 | 141379 | 53072428 |
Arthralgia | 167.74 | 9.79 | 564 | 134695 | 439219 | 52774588 |
Pneumonia | 167.13 | 9.79 | 1670 | 133589 | 405499 | 52808308 |
Glossodynia | 164.69 | 9.79 | 28 | 135231 | 100263 | 53113544 |
Blood potassium decreased | 153.70 | 9.79 | 326 | 134933 | 40134 | 53173673 |
Cardiac arrest | 152.29 | 9.79 | 553 | 134706 | 93114 | 53120693 |
Off label use | 148.88 | 9.79 | 654 | 134605 | 471558 | 52742249 |
Therapeutic product effect decreased | 141.22 | 9.79 | 71 | 135188 | 125584 | 53088223 |
Pain | 134.76 | 9.79 | 907 | 134352 | 587491 | 52626316 |
Acute myocardial infarction | 127.64 | 9.79 | 269 | 134990 | 32966 | 53180841 |
Drug intolerance | 123.30 | 9.79 | 207 | 135052 | 205286 | 53008521 |
Catheter site infection | 121.46 | 9.79 | 101 | 135158 | 4891 | 53208916 |
Abdominal distension | 120.43 | 9.79 | 460 | 134799 | 79330 | 53134477 |
Product use issue | 117.94 | 9.79 | 108 | 135151 | 139476 | 53074331 |
Hyperkalaemia | 115.52 | 9.79 | 351 | 134908 | 53905 | 53159902 |
Colitis microscopic | 110.86 | 9.79 | 112 | 135147 | 6982 | 53206825 |
Infusion related reaction | 110.29 | 9.79 | 140 | 135119 | 155817 | 53057990 |
Fluid retention | 107.56 | 9.79 | 343 | 134916 | 54058 | 53159749 |
Hypervolaemia | 105.91 | 9.79 | 67 | 135192 | 2106 | 53211701 |
Diabetic foot | 104.37 | 9.79 | 61 | 135198 | 1657 | 53212150 |
Respiratory failure | 103.12 | 9.79 | 516 | 134743 | 99996 | 53113811 |
Rash | 102.35 | 9.79 | 687 | 134572 | 445504 | 52768303 |
Pericarditis | 101.37 | 9.79 | 20 | 135239 | 64386 | 53149421 |
Drug hypersensitivity | 101.00 | 9.79 | 340 | 134919 | 264902 | 52948905 |
Cardio-respiratory arrest | 100.66 | 9.79 | 353 | 134906 | 58405 | 53155402 |
Musculoskeletal stiffness | 100.06 | 9.79 | 99 | 135160 | 123269 | 53090538 |
Peritoneal cloudy effluent | 100.01 | 9.79 | 35 | 135224 | 263 | 53213544 |
Drug abuse | 99.73 | 9.79 | 22 | 135237 | 65504 | 53148303 |
Lower respiratory tract infection | 98.38 | 9.79 | 54 | 135205 | 90927 | 53122880 |
Pneumonia aspiration | 97.90 | 9.79 | 247 | 135012 | 34054 | 53179753 |
Bone marrow failure | 96.77 | 9.79 | 227 | 135032 | 29888 | 53183919 |
Wound | 92.43 | 9.79 | 59 | 135200 | 91498 | 53122309 |
Cardiovascular disorder | 90.20 | 9.79 | 133 | 135126 | 12280 | 53201527 |
Pulmonary oedema | 89.66 | 9.79 | 320 | 134939 | 53403 | 53160404 |
Procedural pain | 87.82 | 9.79 | 144 | 135115 | 14573 | 53199234 |
Pleural effusion | 87.53 | 9.79 | 450 | 134809 | 88129 | 53125678 |
Myocardial infarction | 87.48 | 9.79 | 489 | 134770 | 98865 | 53114942 |
Cerebrovascular accident | 86.94 | 9.79 | 509 | 134750 | 104665 | 53109142 |
Disease complication | 85.89 | 9.79 | 69 | 135190 | 3181 | 53210626 |
Hypoxia | 84.81 | 9.79 | 322 | 134937 | 55358 | 53158449 |
Therapeutic product effect incomplete | 82.39 | 9.79 | 67 | 135192 | 91717 | 53122090 |
Malnutrition | 81.41 | 9.79 | 140 | 135119 | 14731 | 53199076 |
Gastrointestinal haemorrhage | 81.39 | 9.79 | 411 | 134848 | 79919 | 53133888 |
Maternal exposure during pregnancy | 79.96 | 9.79 | 172 | 135087 | 155467 | 53058340 |
Oedema peripheral | 79.94 | 9.79 | 721 | 134538 | 170066 | 53043741 |
Multimorbidity | 78.05 | 9.79 | 38 | 135221 | 705 | 53213102 |
Pulmonary hypertension | 74.58 | 9.79 | 236 | 135023 | 37034 | 53176773 |
Hypersensitivity | 73.52 | 9.79 | 280 | 134979 | 210385 | 53003422 |
Headache | 72.67 | 9.79 | 943 | 134316 | 535878 | 52677929 |
Atrial fibrillation | 72.32 | 9.79 | 508 | 134751 | 111144 | 53102663 |
Psoriasis | 71.63 | 9.79 | 69 | 135190 | 87020 | 53126787 |
Cardiac failure | 71.28 | 9.79 | 416 | 134843 | 85428 | 53128379 |
Helicobacter infection | 70.96 | 9.79 | 8 | 135251 | 39061 | 53174746 |
Hypoglycaemia | 69.98 | 9.79 | 316 | 134943 | 58697 | 53155110 |
Acute respiratory failure | 68.19 | 9.79 | 204 | 135055 | 31054 | 53182753 |
Cardiac disorder | 67.76 | 9.79 | 267 | 134992 | 46699 | 53167108 |
Treatment failure | 66.69 | 9.79 | 141 | 135118 | 128262 | 53085545 |
Injection site pain | 66.32 | 9.79 | 116 | 135143 | 113275 | 53100532 |
Nasopharyngitis | 66.18 | 9.79 | 257 | 135002 | 192038 | 53021769 |
Right ventricular failure | 65.44 | 9.79 | 137 | 135122 | 16706 | 53197101 |
Completed suicide | 62.78 | 9.79 | 163 | 135096 | 138038 | 53075769 |
Abortion spontaneous | 62.73 | 9.79 | 20 | 135239 | 46615 | 53167192 |
Asthenia | 62.16 | 9.79 | 1219 | 134040 | 342371 | 52871436 |
Inadequate aseptic technique in use of product | 61.85 | 9.79 | 20 | 135239 | 114 | 53213693 |
Muscle injury | 59.74 | 9.79 | 4 | 135255 | 29762 | 53184045 |
Fatigue | 59.39 | 9.79 | 1406 | 133853 | 729100 | 52484707 |
Psoriatic arthropathy | 59.16 | 9.79 | 24 | 135235 | 48166 | 53165641 |
Electrolyte imbalance | 58.13 | 9.79 | 140 | 135119 | 18744 | 53195063 |
Glaucoma | 57.74 | 9.79 | 131 | 135128 | 16872 | 53196935 |
Mental status changes | 57.11 | 9.79 | 225 | 135034 | 39346 | 53174461 |
Toxicity to various agents | 57.01 | 9.79 | 325 | 134934 | 219273 | 52994534 |
Hepatic enzyme increased | 56.43 | 9.79 | 150 | 135109 | 126045 | 53087762 |
Folliculitis | 56.33 | 9.79 | 7 | 135252 | 31702 | 53182105 |
Suicidal ideation | 55.77 | 9.79 | 43 | 135216 | 60468 | 53153339 |
Abdominal pain | 55.40 | 9.79 | 934 | 134325 | 254969 | 52958838 |
Fluid imbalance | 53.64 | 9.79 | 25 | 135234 | 419 | 53213388 |
Synovitis | 52.32 | 9.79 | 123 | 135136 | 107770 | 53106037 |
Injection site reaction | 51.59 | 9.79 | 33 | 135226 | 51133 | 53162674 |
Abdominal discomfort | 51.21 | 9.79 | 339 | 134920 | 220723 | 52993084 |
Pleuroperitoneal communication | 49.94 | 9.79 | 15 | 135244 | 64 | 53213743 |
Injection site erythema | 49.88 | 9.79 | 74 | 135185 | 77175 | 53136632 |
Asthma | 49.88 | 9.79 | 128 | 135131 | 108844 | 53104963 |
Swelling | 49.50 | 9.79 | 283 | 134976 | 190822 | 53022985 |
Acute kidney injury | 48.00 | 9.79 | 907 | 134352 | 252961 | 52960846 |
Irritable bowel syndrome | 47 | 9.79 | 26 | 135233 | 43606 | 53170201 |
Diverticulitis | 46.46 | 9.79 | 197 | 135062 | 35604 | 53178203 |
Device related infection | 46.24 | 9.79 | 145 | 135114 | 22641 | 53191166 |
Oedema | 46.22 | 9.79 | 335 | 134924 | 74011 | 53139796 |
Sinusitis | 46.18 | 9.79 | 245 | 135014 | 168319 | 53045488 |
Loss of personal independence in daily activities | 45.94 | 9.79 | 66 | 135193 | 69749 | 53144058 |
Non-cardiogenic pulmonary oedema | 45.70 | 9.79 | 25 | 135234 | 596 | 53213211 |
Umbilical hernia | 45.18 | 9.79 | 45 | 135214 | 2757 | 53211050 |
Cytokine release syndrome | 45.11 | 9.79 | 77 | 135182 | 8052 | 53205755 |
Discomfort | 44.58 | 9.79 | 111 | 135148 | 95361 | 53118446 |
Diabetes insipidus | 44.36 | 9.79 | 43 | 135216 | 2548 | 53211259 |
Injection site bruising | 44.21 | 9.79 | 20 | 135239 | 37626 | 53176181 |
Intentional self-injury | 43.90 | 9.79 | 6 | 135253 | 25278 | 53188529 |
Septic shock | 43.76 | 9.79 | 289 | 134970 | 61940 | 53151867 |
Anaemia | 43.52 | 9.79 | 962 | 134297 | 275756 | 52938051 |
Renal ischaemia | 43.43 | 9.79 | 24 | 135235 | 584 | 53213223 |
Noninfectious peritonitis | 43.01 | 9.79 | 18 | 135241 | 230 | 53213577 |
Impaired healing | 42.94 | 9.79 | 60 | 135199 | 64145 | 53149662 |
Sopor | 41.82 | 9.79 | 3 | 135256 | 21081 | 53192726 |
Hernia | 41.67 | 9.79 | 85 | 135174 | 10175 | 53203632 |
Injection site swelling | 40.95 | 9.79 | 29 | 135230 | 42599 | 53171208 |
Diabetic complication | 40.25 | 9.79 | 27 | 135232 | 939 | 53212868 |
Febrile neutropenia | 39.75 | 9.79 | 424 | 134835 | 104512 | 53109295 |
Pregnancy | 39.67 | 9.79 | 15 | 135244 | 31426 | 53182381 |
Hypophagia | 38.83 | 9.79 | 169 | 135090 | 30893 | 53182914 |
Product use in unapproved indication | 38.64 | 9.79 | 150 | 135109 | 112139 | 53101668 |
Blood urea increased | 38.54 | 9.79 | 150 | 135109 | 26081 | 53187726 |
Dyspnoea | 38.28 | 9.79 | 1834 | 133425 | 584398 | 52629409 |
Peritoneal effluent abnormal | 38.09 | 9.79 | 12 | 135247 | 62 | 53213745 |
Arthritis | 38.08 | 9.79 | 105 | 135154 | 87193 | 53126614 |
Ill-defined disorder | 37.46 | 9.79 | 42 | 135217 | 49402 | 53164405 |
PO2 increased | 37.28 | 9.79 | 25 | 135234 | 869 | 53212938 |
Hypernatraemia | 37.16 | 9.79 | 65 | 135194 | 6932 | 53206875 |
Haemoglobin decreased | 36.49 | 9.79 | 519 | 134740 | 136788 | 53077019 |
International normalised ratio increased | 35.53 | 9.79 | 225 | 135034 | 47536 | 53166271 |
Renal failure | 35.28 | 9.79 | 457 | 134802 | 117995 | 53095812 |
Gangrene | 35.06 | 9.79 | 52 | 135207 | 4825 | 53208982 |
Pulmonary arterial hypertension | 35.00 | 9.79 | 149 | 135110 | 26973 | 53186834 |
C-reactive protein abnormal | 34.96 | 9.79 | 11 | 135248 | 25859 | 53187948 |
Treatment noncompliance | 34.84 | 9.79 | 171 | 135088 | 32864 | 53180943 |
Injection site pruritus | 34.13 | 9.79 | 33 | 135226 | 41556 | 53172251 |
Intentional product use issue | 34.06 | 9.79 | 84 | 135175 | 72410 | 53141397 |
Azotaemia | 33.72 | 9.79 | 49 | 135210 | 4464 | 53209343 |
Urticaria | 33.69 | 9.79 | 204 | 135055 | 135681 | 53078126 |
Failure to thrive | 33.36 | 9.79 | 62 | 135197 | 6930 | 53206877 |
Catheter site extravasation | 32.05 | 9.79 | 16 | 135243 | 314 | 53213493 |
Blood pressure decreased | 31.92 | 9.79 | 267 | 134992 | 61602 | 53152205 |
Blood bilirubin increased | 30.85 | 9.79 | 175 | 135084 | 35555 | 53178252 |
Gastrooesophageal reflux disease | 30.83 | 9.79 | 333 | 134926 | 82330 | 53131477 |
Heparin-induced thrombocytopenia | 30.57 | 9.79 | 47 | 135212 | 4502 | 53209305 |
Blood magnesium decreased | 30.55 | 9.79 | 82 | 135177 | 11732 | 53202075 |
PCO2 increased | 29.93 | 9.79 | 25 | 135234 | 1218 | 53212589 |
Pneumoperitoneum | 29.72 | 9.79 | 28 | 135231 | 1601 | 53212206 |
Condition aggravated | 29.53 | 9.79 | 553 | 134706 | 296581 | 52917226 |
Hip arthroplasty | 29.44 | 9.79 | 17 | 135242 | 27845 | 53185962 |
Sleep disorder | 29.43 | 9.79 | 66 | 135193 | 58804 | 53155003 |
Decreased appetite | 29.35 | 9.79 | 733 | 134526 | 214241 | 52999566 |
Inappropriate schedule of product administration | 29.11 | 9.79 | 95 | 135164 | 74783 | 53139024 |
Cor pulmonale | 28.53 | 9.79 | 30 | 135229 | 1960 | 53211847 |
Coma | 28.43 | 9.79 | 260 | 134999 | 61523 | 53152284 |
Therapeutic response decreased | 28.40 | 9.79 | 48 | 135211 | 47521 | 53166286 |
Cardiogenic shock | 28.19 | 9.79 | 103 | 135156 | 17379 | 53196428 |
Brain natriuretic peptide increased | 27.79 | 9.79 | 47 | 135212 | 4878 | 53208929 |
Device occlusion | 27.42 | 9.79 | 56 | 135203 | 6709 | 53207098 |
Atrial flutter | 27.29 | 9.79 | 69 | 135190 | 9522 | 53204285 |
Knee arthroplasty | 27.12 | 9.79 | 27 | 135232 | 33542 | 53180265 |
Chronic obstructive pulmonary disease | 27.09 | 9.79 | 255 | 135004 | 60818 | 53152989 |
Paraesthesia | 26.82 | 9.79 | 201 | 135058 | 127314 | 53086493 |
Cardiac dysfunction | 26.78 | 9.79 | 28 | 135231 | 1817 | 53211990 |
Blood albumin decreased | 26.31 | 9.79 | 89 | 135170 | 14453 | 53199354 |
Multiple sclerosis relapse | 26.10 | 9.79 | 46 | 135213 | 44807 | 53169000 |
Calcium deficiency | 26.03 | 9.79 | 21 | 135238 | 974 | 53212833 |
Red blood cell sedimentation rate increased | 25.77 | 9.79 | 20 | 135239 | 28037 | 53185770 |
Drug interaction | 25.73 | 9.79 | 396 | 134863 | 218933 | 52994874 |
Vomiting | 25.69 | 9.79 | 1522 | 133737 | 495617 | 52718190 |
Blood cholesterol increased | 25.20 | 9.79 | 61 | 135198 | 52928 | 53160879 |
Deep vein thrombosis | 25.14 | 9.79 | 321 | 134938 | 82592 | 53131215 |
Blood glucose decreased | 25.09 | 9.79 | 109 | 135150 | 19907 | 53193900 |
Abdominal hernia | 25.08 | 9.79 | 45 | 135214 | 4895 | 53208912 |
Inflammation | 24.71 | 9.79 | 69 | 135190 | 57067 | 53156740 |
Acute left ventricular failure | 23.95 | 9.79 | 19 | 135240 | 860 | 53212947 |
Thrombocytopenia | 23.93 | 9.79 | 489 | 134770 | 138238 | 53075569 |
Exposure during pregnancy | 23.86 | 9.79 | 202 | 135057 | 124658 | 53089149 |
Encephalopathy | 23.53 | 9.79 | 167 | 135092 | 36641 | 53177166 |
Encapsulating peritoneal sclerosis | 23.41 | 9.79 | 14 | 135245 | 397 | 53213410 |
Wrong product administered | 23.26 | 9.79 | 49 | 135210 | 5999 | 53207808 |
Blood potassium increased | 23.01 | 9.79 | 98 | 135161 | 17743 | 53196064 |
Bronchitis | 22.92 | 9.79 | 405 | 134854 | 111494 | 53102313 |
Plasma cell myeloma | 22.81 | 9.79 | 203 | 135056 | 47671 | 53166136 |
Drug reaction with eosinophilia and systemic symptoms | 22.58 | 9.79 | 30 | 135229 | 32770 | 53181037 |
Migraine | 22.49 | 9.79 | 116 | 135143 | 80301 | 53133506 |
Pruritus | 22.22 | 9.79 | 571 | 134688 | 293261 | 52920546 |
Wrong technique in product usage process | 22.08 | 9.79 | 78 | 135181 | 59954 | 53153853 |
Blood bicarbonate decreased | 21.90 | 9.79 | 32 | 135227 | 2930 | 53210877 |
White blood cell count decreased | 21.87 | 9.79 | 440 | 134819 | 124035 | 53089772 |
Hypovolaemia | 21.85 | 9.79 | 67 | 135192 | 10335 | 53203472 |
Hyperglycaemia | 21.76 | 9.79 | 175 | 135084 | 39909 | 53173898 |
Herpes zoster | 21.72 | 9.79 | 105 | 135154 | 73914 | 53139893 |
Disability | 21.62 | 9.79 | 3 | 135256 | 12495 | 53201312 |
Serotonin syndrome | 21.61 | 9.79 | 21 | 135238 | 26385 | 53187422 |
Pulse absent | 21.60 | 9.79 | 44 | 135215 | 5262 | 53208545 |
Tonsillar haemorrhage | 21.45 | 9.79 | 11 | 135248 | 229 | 53213578 |
Bacteraemia | 21.30 | 9.79 | 87 | 135172 | 15462 | 53198345 |
Multiple organ dysfunction syndrome | 21.08 | 9.79 | 225 | 135034 | 55452 | 53158355 |
Extremity necrosis | 21.08 | 9.79 | 24 | 135235 | 1715 | 53212092 |
Urine chloride decreased | 21.04 | 9.79 | 8 | 135251 | 78 | 53213729 |
Haemorrhage | 20.88 | 9.79 | 232 | 135027 | 57755 | 53156052 |
Cardiomegaly | 20.85 | 9.79 | 95 | 135164 | 17705 | 53196102 |
Urinary tract infection | 20.64 | 9.79 | 773 | 134486 | 239130 | 52974677 |
Peritoneal effluent leukocyte count increased | 20.28 | 9.79 | 6 | 135253 | 24 | 53213783 |
Product selection error | 20.27 | 9.79 | 8 | 135251 | 87 | 53213720 |
Respiratory distress | 20.20 | 9.79 | 151 | 135108 | 33676 | 53180131 |
Muscle spasticity | 20.14 | 9.79 | 10 | 135249 | 17828 | 53195979 |
Metabolic alkalosis | 20.02 | 9.79 | 31 | 135228 | 2988 | 53210819 |
Posterior reversible encephalopathy syndrome | 19.91 | 9.79 | 8 | 135251 | 16152 | 53197655 |
Transfusion | 19.88 | 9.79 | 78 | 135181 | 13609 | 53200198 |
Vertigo | 19.88 | 9.79 | 74 | 135185 | 56007 | 53157800 |
Insomnia | 19.87 | 9.79 | 344 | 134915 | 186728 | 53027079 |
Small intestinal obstruction | 19.70 | 9.79 | 91 | 135168 | 17056 | 53196751 |
Joint stiffness | 19.55 | 9.79 | 29 | 135230 | 30254 | 53183553 |
Prothrombin time prolonged | 19.46 | 9.79 | 62 | 135197 | 9760 | 53204047 |
Staphylococcus test positive | 19.31 | 9.79 | 35 | 135224 | 3838 | 53209969 |
Electrocardiogram T wave peaked | 19.13 | 9.79 | 10 | 135249 | 217 | 53213590 |
Bacterial translocation | 19.13 | 9.79 | 10 | 135249 | 217 | 53213590 |
Hepatocellular injury | 19.08 | 9.79 | 29 | 135230 | 29957 | 53183850 |
Gastrointestinal disorder | 18.86 | 9.79 | 142 | 135117 | 89862 | 53123945 |
Blood pH decreased | 18.85 | 9.79 | 28 | 135231 | 2602 | 53211205 |
Unresponsive to stimuli | 18.72 | 9.79 | 147 | 135112 | 33279 | 53180528 |
Cognitive disorder | 18.68 | 9.79 | 55 | 135204 | 44723 | 53169084 |
Foot deformity | 18.68 | 9.79 | 12 | 135247 | 18556 | 53195251 |
Metabolic encephalopathy | 18.63 | 9.79 | 44 | 135215 | 5817 | 53207990 |
Cardiac failure acute | 18.57 | 9.79 | 58 | 135201 | 9034 | 53204773 |
Diarrhoea | 18.54 | 9.79 | 1833 | 133426 | 623713 | 52590094 |
Hypomagnesaemia | 18.52 | 9.79 | 117 | 135142 | 24694 | 53189113 |
Catheter management | 18.51 | 9.79 | 29 | 135230 | 2823 | 53210984 |
Tendonitis | 18.51 | 9.79 | 10 | 135249 | 16996 | 53196811 |
Osteonecrosis of jaw | 18.49 | 9.79 | 40 | 135219 | 36106 | 53177701 |
Osteoarthritis | 18.43 | 9.79 | 104 | 135155 | 70382 | 53143425 |
Hypoalbuminaemia | 18.11 | 9.79 | 65 | 135194 | 10871 | 53202936 |
Overdose | 18.11 | 9.79 | 180 | 135079 | 107556 | 53106251 |
Gait disturbance | 17.87 | 9.79 | 289 | 134970 | 158553 | 53055254 |
Acne | 17.86 | 9.79 | 17 | 135242 | 21569 | 53192238 |
Grip strength decreased | 17.76 | 9.79 | 4 | 135255 | 11745 | 53202062 |
Oxygen consumption increased | 17.63 | 9.79 | 33 | 135226 | 3708 | 53210099 |
Procedural complication | 17.52 | 9.79 | 40 | 135219 | 5172 | 53208635 |
Injection site warmth | 17.40 | 9.79 | 7 | 135252 | 14121 | 53199686 |
Peritoneal disorder | 17.35 | 9.79 | 13 | 135246 | 540 | 53213267 |
Blood glucose increased | 17.29 | 9.79 | 284 | 134975 | 77077 | 53136730 |
Generalised oedema | 17.25 | 9.79 | 80 | 135179 | 15019 | 53198788 |
Full blood count decreased | 17.13 | 9.79 | 112 | 135147 | 23917 | 53189890 |
Blister | 17.10 | 9.79 | 123 | 135136 | 78630 | 53135177 |
Oxygen saturation abnormal | 17.07 | 9.79 | 28 | 135231 | 2834 | 53210973 |
Abdominal pain upper | 16.95 | 9.79 | 308 | 134951 | 165983 | 53047824 |
Hepatitis | 16.93 | 9.79 | 38 | 135221 | 33856 | 53179951 |
Device related sepsis | 16.93 | 9.79 | 32 | 135227 | 3623 | 53210184 |
Granulocytopenia | 16.87 | 9.79 | 41 | 135218 | 5519 | 53208288 |
Mental status changes postoperative | 16.78 | 9.79 | 9 | 135250 | 206 | 53213601 |
Device difficult to use | 16.76 | 9.79 | 3 | 135256 | 10356 | 53203451 |
Mobility decreased | 16.62 | 9.79 | 119 | 135140 | 76152 | 53137655 |
Blood calcium decreased | 16.46 | 9.79 | 96 | 135163 | 19698 | 53194109 |
Injection site rash | 16.29 | 9.79 | 11 | 135248 | 16568 | 53197239 |
Corneal oedema | 16.26 | 9.79 | 22 | 135237 | 1875 | 53211932 |
Blood potassium abnormal | 16.20 | 9.79 | 25 | 135234 | 2402 | 53211405 |
Pain in extremity | 16.09 | 9.79 | 576 | 134683 | 284474 | 52929333 |
Hydrothorax | 15.84 | 9.79 | 14 | 135245 | 737 | 53213070 |
Extravasation | 15.84 | 9.79 | 24 | 135235 | 2270 | 53211537 |
Tenosynovitis | 15.82 | 9.79 | 3 | 135256 | 9936 | 53203871 |
Oropharyngeal pain | 15.74 | 9.79 | 131 | 135128 | 81137 | 53132670 |
Fibromyalgia | 15.72 | 9.79 | 58 | 135201 | 44017 | 53169790 |
Intentional product misuse | 15.72 | 9.79 | 68 | 135191 | 49324 | 53164483 |
Chest pain | 15.68 | 9.79 | 610 | 134649 | 189575 | 53024232 |
Suicide attempt | 15.66 | 9.79 | 85 | 135174 | 58083 | 53155724 |
Haematocrit decreased | 15.63 | 9.79 | 154 | 135105 | 37177 | 53176630 |
Urine sodium decreased | 15.62 | 9.79 | 8 | 135251 | 166 | 53213641 |
Arrhythmia | 15.53 | 9.79 | 152 | 135107 | 36627 | 53177180 |
Decubitus ulcer | 15.41 | 9.79 | 60 | 135199 | 10433 | 53203374 |
Product storage error | 15.38 | 9.79 | 7 | 135252 | 13123 | 53200684 |
Ventricular tachycardia | 15.33 | 9.79 | 87 | 135172 | 17675 | 53196132 |
Ascites | 15.24 | 9.79 | 161 | 135098 | 39574 | 53174233 |
Marasmus | 15.19 | 9.79 | 12 | 135247 | 540 | 53213267 |
Supraventricular tachycardia | 14.99 | 9.79 | 74 | 135185 | 14251 | 53199556 |
Acinetobacter sepsis | 14.94 | 9.79 | 3 | 135256 | 0 | 53213807 |
Vascular device infection | 14.94 | 9.79 | 34 | 135225 | 4387 | 53209420 |
Clostridium difficile infection | 14.72 | 9.79 | 121 | 135138 | 27772 | 53186035 |
Blood alkaline phosphatase increased | 14.67 | 9.79 | 165 | 135094 | 41197 | 53172610 |
Critical illness | 14.65 | 9.79 | 8 | 135251 | 190 | 53213617 |
Pancytopenia | 14.53 | 9.79 | 317 | 134942 | 90611 | 53123196 |
Pharyngitis | 14.51 | 9.79 | 16 | 135243 | 18964 | 53194843 |
Oxalosis | 14.47 | 9.79 | 5 | 135254 | 36 | 53213771 |
Activated partial thromboplastin time prolonged | 14.39 | 9.79 | 45 | 135214 | 7014 | 53206793 |
Impaired work ability | 14.32 | 9.79 | 9 | 135250 | 14081 | 53199726 |
Atelectasis | 14.28 | 9.79 | 93 | 135166 | 19833 | 53193974 |
Dry eye | 14.27 | 9.79 | 41 | 135218 | 33603 | 53180204 |
Platelet count decreased | 14.26 | 9.79 | 367 | 134892 | 107732 | 53106075 |
Accidental exposure to product | 14.03 | 9.79 | 24 | 135235 | 23650 | 53190157 |
Depression | 14.01 | 9.79 | 355 | 134904 | 182697 | 53031110 |
Interstitial lung disease | 14.00 | 9.79 | 89 | 135170 | 58533 | 53155274 |
Colitis | 13.95 | 9.79 | 164 | 135095 | 41388 | 53172419 |
Tachypnoea | 13.91 | 9.79 | 78 | 135181 | 15776 | 53198031 |
Catheter site haemorrhage | 13.84 | 9.79 | 26 | 135233 | 2929 | 53210878 |
Hyponatraemia | 13.83 | 9.79 | 367 | 134892 | 108240 | 53105567 |
Skin dystrophy | 13.80 | 9.79 | 5 | 135254 | 42 | 53213765 |
Hot flush | 13.77 | 9.79 | 67 | 135192 | 47093 | 53166714 |
Stomatitis | 13.72 | 9.79 | 171 | 135088 | 97987 | 53115820 |
Product substitution issue | 13.71 | 9.79 | 12 | 135247 | 15854 | 53197953 |
Shock | 13.65 | 9.79 | 103 | 135156 | 23036 | 53190771 |
Posthaemorrhagic hydrocephalus | 13.52 | 9.79 | 4 | 135255 | 16 | 53213791 |
Escherichia peritonitis | 13.52 | 9.79 | 4 | 135255 | 16 | 53213791 |
Ventricular fibrillation | 13.49 | 9.79 | 63 | 135196 | 11862 | 53201945 |
Cholelithiasis | 13.45 | 9.79 | 161 | 135098 | 40803 | 53173004 |
Abdominal incarcerated hernia | 13.33 | 9.79 | 4 | 135255 | 17 | 53213790 |
Nutritional condition abnormal | 13.32 | 9.79 | 13 | 135246 | 777 | 53213030 |
Catheter site abscess | 13.31 | 9.79 | 5 | 135254 | 47 | 53213760 |
Nosocomial infection | 13.23 | 9.79 | 19 | 135240 | 1712 | 53212095 |
Coeliac disease | 13.15 | 9.79 | 3 | 135256 | 8732 | 53205075 |
Poisoning deliberate | 13.10 | 9.79 | 3 | 135256 | 8710 | 53205097 |
Product compounding quality issue | 13.07 | 9.79 | 6 | 135253 | 97 | 53213710 |
Drug resistance | 13 | 9.79 | 19 | 135240 | 19943 | 53193864 |
Product residue present | 12.99 | 9.79 | 31 | 135228 | 4125 | 53209682 |
Oral herpes | 12.99 | 9.79 | 21 | 135238 | 21158 | 53192649 |
Postoperative adhesion | 12.98 | 9.79 | 8 | 135251 | 240 | 53213567 |
Movement disorder | 12.95 | 9.79 | 17 | 135242 | 18664 | 53195143 |
Blood chloride decreased | 12.92 | 9.79 | 37 | 135222 | 5494 | 53208313 |
Confusion postoperative | 12.86 | 9.79 | 8 | 135251 | 244 | 53213563 |
Blood creatinine increased | 12.83 | 9.79 | 287 | 134972 | 82375 | 53131432 |
Aspartate aminotransferase increased | 12.81 | 9.79 | 291 | 134968 | 83738 | 53130069 |
Akathisia | 12.79 | 9.79 | 3 | 135256 | 8568 | 53205239 |
Post procedural complication | 12.69 | 9.79 | 79 | 135180 | 16587 | 53197220 |
Foetal death | 12.57 | 9.79 | 52 | 135207 | 9295 | 53204512 |
Poisoning | 12.56 | 9.79 | 10 | 135249 | 13840 | 53199967 |
Psychomotor hyperactivity | 12.43 | 9.79 | 5 | 135254 | 10091 | 53203716 |
Toxic epidermal necrolysis | 12.34 | 9.79 | 102 | 135157 | 23448 | 53190359 |
Depressed mood | 12.31 | 9.79 | 50 | 135209 | 36914 | 53176893 |
Alkalosis | 12.27 | 9.79 | 9 | 135250 | 362 | 53213445 |
Sudden death | 12.23 | 9.79 | 55 | 135204 | 10193 | 53203614 |
Cyst | 12.12 | 9.79 | 9 | 135250 | 12902 | 53200905 |
Torsade de pointes | 12.09 | 9.79 | 65 | 135194 | 12940 | 53200867 |
Ileus | 12.09 | 9.79 | 72 | 135187 | 14883 | 53198924 |
Thrombosis | 12.07 | 9.79 | 219 | 135040 | 60574 | 53153233 |
Obstructive airways disorder | 11.94 | 9.79 | 16 | 135243 | 17413 | 53196394 |
Nodule | 11.94 | 9.79 | 16 | 135243 | 17413 | 53196394 |
Chronic kidney disease | 11.93 | 9.79 | 165 | 135094 | 43205 | 53170602 |
Calciphylaxis | 11.89 | 9.79 | 24 | 135235 | 2851 | 53210956 |
Cellulitis | 11.85 | 9.79 | 264 | 134995 | 75725 | 53138082 |
Hypoaesthesia | 11.83 | 9.79 | 252 | 135007 | 132743 | 53081064 |
Hyperoxaluria | 11.78 | 9.79 | 6 | 135253 | 123 | 53213684 |
Haemodynamic instability | 11.70 | 9.79 | 48 | 135211 | 8546 | 53205261 |
Upper gastrointestinal haemorrhage | 11.68 | 9.79 | 80 | 135179 | 17350 | 53196457 |
Thyroid disorder | 11.63 | 9.79 | 66 | 135193 | 13407 | 53200400 |
Adverse event | 11.61 | 9.79 | 59 | 135200 | 41002 | 53172805 |
Cardiovascular insufficiency | 11.59 | 9.79 | 16 | 135243 | 1390 | 53212417 |
Urosepsis | 11.58 | 9.79 | 77 | 135182 | 16533 | 53197274 |
Incision site pain | 11.52 | 9.79 | 14 | 135245 | 1072 | 53212735 |
Pseudomonal bacteraemia | 11.51 | 9.79 | 16 | 135243 | 1399 | 53212408 |
Blood pressure diastolic abnormal | 11.32 | 9.79 | 4 | 135255 | 8741 | 53205066 |
Gastrointestinal stoma output decreased | 11.32 | 9.79 | 4 | 135255 | 31 | 53213776 |
Incarcerated hernia | 11.32 | 9.79 | 6 | 135253 | 134 | 53213673 |
Infantile apnoea | 11.30 | 9.79 | 13 | 135246 | 939 | 53212868 |
Sedation | 11.29 | 9.79 | 38 | 135221 | 29637 | 53184170 |
Schizophrenia | 11.25 | 9.79 | 6 | 135253 | 10273 | 53203534 |
Coagulopathy | 11.24 | 9.79 | 87 | 135172 | 19611 | 53194196 |
Tissue injury | 11.21 | 9.79 | 4 | 135255 | 32 | 53213775 |
Pericardial effusion | 11.16 | 9.79 | 112 | 135147 | 27166 | 53186641 |
Panniculitis | 11.15 | 9.79 | 3 | 135256 | 7811 | 53205996 |
Cardiac procedure complication | 11.12 | 9.79 | 7 | 135252 | 218 | 53213589 |
Type 2 diabetes mellitus | 11.08 | 9.79 | 42 | 135217 | 31628 | 53182179 |
Hip fracture | 11.07 | 9.79 | 115 | 135144 | 28142 | 53185665 |
Labelled drug-drug interaction medication error | 11.02 | 9.79 | 7 | 135252 | 10892 | 53202915 |
Cytotoxic oedema | 11.01 | 9.79 | 6 | 135253 | 142 | 53213665 |
Myalgia | 11 | 9.79 | 256 | 135003 | 133235 | 53080572 |
Abortion induced | 10.89 | 9.79 | 7 | 135252 | 10819 | 53202988 |
Leukocytosis | 10.83 | 9.79 | 103 | 135156 | 24631 | 53189176 |
Device leakage | 10.81 | 9.79 | 37 | 135222 | 6043 | 53207764 |
Gallbladder necrosis | 10.80 | 9.79 | 3 | 135256 | 9 | 53213798 |
Sinoatrial block | 10.80 | 9.79 | 12 | 135247 | 835 | 53212972 |
Urine output decreased | 10.75 | 9.79 | 58 | 135201 | 11565 | 53202242 |
Disseminated intravascular coagulation | 10.65 | 9.79 | 86 | 135173 | 19633 | 53194174 |
Central nervous system injury | 10.64 | 9.79 | 6 | 135253 | 152 | 53213655 |
Ear pain | 10.61 | 9.79 | 39 | 135220 | 29634 | 53184173 |
Corynebacterium test positive | 10.61 | 9.79 | 4 | 135255 | 38 | 53213769 |
Serratia sepsis | 10.61 | 9.79 | 5 | 135254 | 86 | 53213721 |
Stress | 10.61 | 9.79 | 93 | 135166 | 56991 | 53156816 |
Night sweats | 10.58 | 9.79 | 49 | 135210 | 34898 | 53178909 |
Product quality issue | 10.58 | 9.79 | 53 | 135206 | 36970 | 53176837 |
Clostridium difficile colitis | 10.57 | 9.79 | 86 | 135173 | 19679 | 53194128 |
Vascular access malfunction | 10.52 | 9.79 | 4 | 135255 | 39 | 53213768 |
Product preparation error | 10.52 | 9.79 | 30 | 135229 | 4445 | 53209362 |
Retinal ischaemia | 10.50 | 9.79 | 8 | 135251 | 341 | 53213466 |
Acidosis hyperchloraemic | 10.44 | 9.79 | 8 | 135251 | 344 | 53213463 |
Basal cell carcinoma | 10.40 | 9.79 | 28 | 135231 | 23441 | 53190366 |
Staphylococcal infection | 10.34 | 9.79 | 146 | 135113 | 38402 | 53175405 |
Oncologic complication | 10.33 | 9.79 | 6 | 135253 | 161 | 53213646 |
Hyperdynamic left ventricle | 10.30 | 9.79 | 6 | 135253 | 162 | 53213645 |
Hyperchloraemia | 10.21 | 9.79 | 11 | 135248 | 739 | 53213068 |
Diabetic vascular disorder | 10.17 | 9.79 | 4 | 135255 | 43 | 53213764 |
Pseudomonas peritonitis | 10.14 | 9.79 | 3 | 135256 | 12 | 53213795 |
Influenza like illness | 10.09 | 9.79 | 102 | 135157 | 60757 | 53153050 |
Blood aldosterone abnormal | 10.01 | 9.79 | 4 | 135255 | 45 | 53213762 |
Extrapyramidal disorder | 9.99 | 9.79 | 10 | 135249 | 12392 | 53201415 |
Chronic respiratory failure | 9.95 | 9.79 | 17 | 135242 | 1779 | 53212028 |
Fibrin | 9.93 | 9.79 | 4 | 135255 | 46 | 53213761 |
Overgrowth bacterial | 9.93 | 9.79 | 5 | 135254 | 100 | 53213707 |
Joint range of motion decreased | 9.93 | 9.79 | 19 | 135240 | 17937 | 53195870 |
Intestinal obstruction | 9.89 | 9.79 | 114 | 135145 | 28627 | 53185180 |
Blood calcium abnormal | 9.85 | 9.79 | 13 | 135246 | 1082 | 53212725 |
Immune effector cell-associated neurotoxicity syndrome | 9.80 | 9.79 | 13 | 135246 | 1087 | 53212720 |
Neutrophil count decreased | 9.80 | 9.79 | 177 | 135082 | 48921 | 53164886 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Peritonitis bacterial | 2932.78 | 10.39 | 1186 | 98258 | 11310 | 32402772 |
Peritonitis | 2098.00 | 10.39 | 1124 | 98320 | 21206 | 32392876 |
Death | 1838.82 | 10.39 | 3764 | 95680 | 378753 | 32035329 |
Peritoneal dialysis complication | 1235.60 | 10.39 | 472 | 98972 | 3796 | 32410286 |
Fluid overload | 1089.05 | 10.39 | 703 | 98741 | 18918 | 32395164 |
Abdominal distension | 356.01 | 10.39 | 595 | 98849 | 50700 | 32363382 |
Ultrafiltration failure | 308.54 | 10.39 | 108 | 99336 | 655 | 32413427 |
Fungal peritonitis | 304.75 | 10.39 | 127 | 99317 | 1309 | 32412773 |
Drug ineffective | 264.67 | 10.39 | 482 | 98962 | 382995 | 32031087 |
Bloody peritoneal effluent | 246.87 | 10.39 | 85 | 99359 | 487 | 32413595 |
Sepsis | 245.15 | 10.39 | 1048 | 98396 | 157786 | 32256296 |
Catheter site infection | 199.33 | 10.39 | 117 | 99327 | 2637 | 32411445 |
Procedural pain | 196.84 | 10.39 | 150 | 99294 | 5279 | 32408803 |
Drug abuse | 175.54 | 10.39 | 20 | 99424 | 80223 | 32333859 |
Cardiac failure congestive | 168.04 | 10.39 | 606 | 98838 | 84246 | 32329836 |
Hypotension | 167.97 | 10.39 | 1183 | 98261 | 214927 | 32199155 |
Hypokalaemia | 154.09 | 10.39 | 443 | 99001 | 54651 | 32359431 |
Cardiac arrest | 149.34 | 10.39 | 639 | 98805 | 96137 | 32317945 |
Peritoneal cloudy effluent | 141.77 | 10.39 | 53 | 99391 | 398 | 32413684 |
Cardiac disorder | 137.35 | 10.39 | 357 | 99087 | 41509 | 32372573 |
Off label use | 136.94 | 10.39 | 480 | 98964 | 305840 | 32108242 |
Diabetic foot | 129.04 | 10.39 | 91 | 99353 | 2835 | 32411247 |
Fluid retention | 128.62 | 10.39 | 264 | 99180 | 26286 | 32387796 |
Cardiac failure | 118.79 | 10.39 | 575 | 98869 | 91098 | 32322984 |
Dehydration | 113.16 | 10.39 | 728 | 98716 | 128230 | 32285852 |
Multimorbidity | 109.19 | 10.39 | 47 | 99397 | 528 | 32413554 |
Drug interaction | 106.23 | 10.39 | 329 | 99115 | 217856 | 32196226 |
Inadequate aseptic technique in use of product | 102.28 | 10.39 | 33 | 99411 | 149 | 32413933 |
Hypervolaemia | 99.70 | 10.39 | 74 | 99370 | 2500 | 32411582 |
Device related infection | 97.30 | 10.39 | 187 | 99257 | 17746 | 32396336 |
Hernia | 93.73 | 10.39 | 130 | 99314 | 9385 | 32404697 |
Rheumatoid arthritis | 92.77 | 10.39 | 13 | 99431 | 44531 | 32369551 |
Toxicity to various agents | 91.27 | 10.39 | 262 | 99182 | 177779 | 32236303 |
Disease complication | 91.13 | 10.39 | 73 | 99371 | 2766 | 32411316 |
Cardiovascular disorder | 87.09 | 10.39 | 134 | 99310 | 10628 | 32403454 |
Cardio-respiratory arrest | 85.72 | 10.39 | 369 | 99075 | 55620 | 32358462 |
Inguinal hernia | 84.93 | 10.39 | 113 | 99331 | 7839 | 32406243 |
Fluid imbalance | 83.35 | 10.39 | 36 | 99408 | 408 | 32413674 |
Appendicolith | 76.22 | 10.39 | 69 | 99375 | 3096 | 32410986 |
Headache | 76.16 | 10.39 | 325 | 99119 | 195872 | 32218210 |
Acute myocardial infarction | 73.60 | 10.39 | 349 | 99095 | 54800 | 32359282 |
Suicide attempt | 69.19 | 10.39 | 16 | 99428 | 38228 | 32375854 |
Diabetic complication | 65.88 | 10.39 | 39 | 99405 | 893 | 32413189 |
Noninfectious peritonitis | 63.24 | 10.39 | 25 | 99419 | 222 | 32413860 |
Azotaemia | 63.06 | 10.39 | 80 | 99364 | 5294 | 32408788 |
Arthralgia | 62.55 | 10.39 | 238 | 99206 | 148210 | 32265872 |
Myocardial infarction | 62.52 | 10.39 | 623 | 98821 | 125053 | 32289029 |
Psoriasis | 61.66 | 10.39 | 32 | 99412 | 46091 | 32367991 |
Treatment failure | 60.55 | 10.39 | 22 | 99422 | 39141 | 32374941 |
Therapeutic product effect incomplete | 59.37 | 10.39 | 26 | 99418 | 41315 | 32372767 |
Peritoneal disorder | 59.26 | 10.39 | 28 | 99416 | 397 | 32413685 |
Pneumonia | 59.19 | 10.39 | 1462 | 97982 | 353790 | 32060292 |
Myelosuppression | 58.78 | 10.39 | 118 | 99326 | 11558 | 32402524 |
Cardiogenic shock | 58.53 | 10.39 | 167 | 99277 | 20495 | 32393587 |
Heparin-induced thrombocytopenia | 56.17 | 10.39 | 78 | 99366 | 5636 | 32408446 |
Blood potassium decreased | 55.95 | 10.39 | 147 | 99297 | 17191 | 32396891 |
Umbilical hernia | 55.63 | 10.39 | 67 | 99377 | 4203 | 32409879 |
Peritoneal effluent abnormal | 54.94 | 10.39 | 20 | 99424 | 138 | 32413944 |
Pulmonary oedema | 54.75 | 10.39 | 283 | 99161 | 45984 | 32368098 |
Overdose | 52.38 | 10.39 | 118 | 99326 | 86959 | 32327123 |
Device occlusion | 50.79 | 10.39 | 82 | 99362 | 6776 | 32407306 |
Injection site pain | 50.38 | 10.39 | 19 | 99425 | 33039 | 32381043 |
Abdominal pain | 50.15 | 10.39 | 687 | 98757 | 148842 | 32265240 |
Product use in unapproved indication | 44.84 | 10.39 | 128 | 99316 | 87076 | 32327006 |
Appendicitis | 44.60 | 10.39 | 90 | 99354 | 8847 | 32405235 |
Hyperkalaemia | 42.87 | 10.39 | 362 | 99082 | 69388 | 32344694 |
Drug reaction with eosinophilia and systemic symptoms | 42.73 | 10.39 | 23 | 99421 | 32462 | 32381620 |
Administration site extravasation | 42.26 | 10.39 | 24 | 99420 | 507 | 32413575 |
Incision site pain | 40.61 | 10.39 | 40 | 99404 | 1997 | 32412085 |
Myalgia | 40.48 | 10.39 | 121 | 99323 | 81109 | 32332973 |
Multiple organ dysfunction syndrome | 39.01 | 10.39 | 355 | 99089 | 69499 | 32344583 |
Intentional product misuse | 38.71 | 10.39 | 32 | 99412 | 36019 | 32378063 |
Gangrene | 38.39 | 10.39 | 60 | 99384 | 4822 | 32409260 |
Hydrothorax | 36.43 | 10.39 | 22 | 99422 | 523 | 32413559 |
Treatment noncompliance | 34.00 | 10.39 | 169 | 99275 | 27033 | 32387049 |
Suicidal ideation | 33.76 | 10.39 | 40 | 99404 | 38043 | 32376039 |
Drug resistance | 33.68 | 10.39 | 14 | 99430 | 22951 | 32391131 |
Fatigue | 33.00 | 10.39 | 819 | 98625 | 349882 | 32064200 |
Cardiac procedure complication | 32.88 | 10.39 | 16 | 99428 | 243 | 32413839 |
Drug intolerance | 32.77 | 10.39 | 65 | 99379 | 50170 | 32363912 |
Serotonin syndrome | 32.64 | 10.39 | 9 | 99435 | 19108 | 32394974 |
Mental status changes | 32.05 | 10.39 | 214 | 99230 | 38123 | 32375959 |
Asthma | 31.42 | 10.39 | 54 | 99390 | 44011 | 32370071 |
Localised infection | 31.30 | 10.39 | 110 | 99334 | 15077 | 32399005 |
Angioedema | 31.23 | 10.39 | 39 | 99405 | 36250 | 32377832 |
Malnutrition | 31.20 | 10.39 | 96 | 99348 | 12282 | 32401800 |
Aggression | 31.19 | 10.39 | 45 | 99399 | 39344 | 32374738 |
Depression | 31.07 | 10.39 | 172 | 99272 | 96888 | 32317194 |
Somnolence | 31.05 | 10.39 | 188 | 99256 | 103609 | 32310473 |
Failure to thrive | 30.85 | 10.39 | 75 | 99369 | 8360 | 32405722 |
Oedema | 30.80 | 10.39 | 240 | 99204 | 44907 | 32369175 |
Intentional product use issue | 30.77 | 10.39 | 51 | 99393 | 42160 | 32371922 |
Insomnia | 30.42 | 10.39 | 181 | 99263 | 100167 | 32313915 |
Joint swelling | 29.58 | 10.39 | 72 | 99372 | 51663 | 32362419 |
Spinal muscular atrophy | 29.36 | 10.39 | 16 | 99428 | 311 | 32413771 |
Intentional overdose | 28.74 | 10.39 | 52 | 99392 | 41549 | 32372533 |
Musculoskeletal stiffness | 28.10 | 10.39 | 48 | 99396 | 39216 | 32374866 |
Staphylococcus test positive | 27.87 | 10.39 | 41 | 99403 | 3124 | 32410958 |
Gastrointestinal haemorrhage | 27.79 | 10.39 | 396 | 99048 | 86486 | 32327596 |
Abdominal hernia | 27.70 | 10.39 | 39 | 99405 | 2854 | 32411228 |
Rash | 27.66 | 10.39 | 462 | 98982 | 208871 | 32205211 |
Drug dependence | 27.57 | 10.39 | 19 | 99425 | 23465 | 32390617 |
Cytokine release syndrome | 27.01 | 10.39 | 97 | 99347 | 13438 | 32400644 |
Mycobacterial peritonitis | 26.99 | 10.39 | 9 | 99435 | 46 | 32414036 |
Interstitial lung disease | 26.82 | 10.39 | 105 | 99339 | 64896 | 32349186 |
Product use issue | 26.73 | 10.39 | 78 | 99366 | 52699 | 32361383 |
Complication associated with device | 26.63 | 10.39 | 58 | 99386 | 6014 | 32408068 |
Loss of personal independence in daily activities | 26.20 | 10.39 | 26 | 99418 | 26807 | 32387275 |
Blood glucose decreased | 26.17 | 10.39 | 96 | 99348 | 13438 | 32400644 |
Diaphragmatic spasm | 25.99 | 10.39 | 10 | 99434 | 82 | 32414000 |
Blood urea increased | 25.69 | 10.39 | 178 | 99266 | 32095 | 32381987 |
Lower respiratory tract infection | 25.61 | 10.39 | 31 | 99413 | 29212 | 32384870 |
Respiratory failure | 25.12 | 10.39 | 464 | 98980 | 106718 | 32307364 |
Cerebrovascular accident | 25.09 | 10.39 | 387 | 99057 | 85933 | 32328149 |
Faecal volume decreased | 24.61 | 10.39 | 10 | 99434 | 96 | 32413986 |
Eosinophilia | 24.58 | 10.39 | 24 | 99420 | 24934 | 32389148 |
Sedation | 24.53 | 10.39 | 13 | 99431 | 18513 | 32395569 |
Anxiety | 23.69 | 10.39 | 184 | 99260 | 95821 | 32318261 |
Tachypnoea | 23.68 | 10.39 | 108 | 99336 | 16675 | 32397407 |
Asthenia | 23.33 | 10.39 | 912 | 98532 | 235032 | 32179050 |
Constipation | 23.31 | 10.39 | 528 | 98916 | 125845 | 32288237 |
Disturbance in attention | 23.21 | 10.39 | 23 | 99421 | 23730 | 32390352 |
Osteonecrosis of jaw | 23.18 | 10.39 | 15 | 99429 | 19151 | 32394931 |
Sopor | 23.16 | 10.39 | 4 | 99440 | 11745 | 32402337 |
Therapeutic product effect decreased | 23.05 | 10.39 | 37 | 99407 | 30980 | 32383102 |
Contraindicated product administered | 22.98 | 10.39 | 15 | 99429 | 19061 | 32395021 |
Psoriatic arthropathy | 22.97 | 10.39 | 13 | 99431 | 17847 | 32396235 |
Hypoglycaemia | 22.97 | 10.39 | 261 | 99183 | 54121 | 32359961 |
Intentional self-injury | 22.89 | 10.39 | 7 | 99437 | 13893 | 32400189 |
Right ventricular failure | 22.61 | 10.39 | 67 | 99377 | 8396 | 32405686 |
Inappropriate schedule of product administration | 22.29 | 10.39 | 69 | 99375 | 45756 | 32368326 |
Therapeutic response decreased | 22.15 | 10.39 | 28 | 99416 | 25892 | 32388190 |
Completed suicide | 22.05 | 10.39 | 179 | 99265 | 92338 | 32321744 |
Product substitution issue | 21.83 | 10.39 | 3 | 99441 | 10433 | 32403649 |
Gait disturbance | 21.32 | 10.39 | 151 | 99293 | 80257 | 32333825 |
Calciphylaxis | 21.13 | 10.39 | 22 | 99422 | 1174 | 32412908 |
Hip fracture | 21.11 | 10.39 | 82 | 99362 | 11793 | 32402289 |
Extremity necrosis | 20.85 | 10.39 | 27 | 99417 | 1823 | 32412259 |
Blood potassium increased | 20.71 | 10.39 | 104 | 99340 | 16700 | 32397382 |
Sputum increased | 20.46 | 10.39 | 29 | 99415 | 2136 | 32411946 |
Ascites | 20.30 | 10.39 | 200 | 99244 | 39991 | 32374091 |
Cytomegalovirus infection | 20.25 | 10.39 | 29 | 99415 | 25435 | 32388647 |
Swelling | 20.19 | 10.39 | 192 | 99252 | 38030 | 32376052 |
Ureteric compression | 20.15 | 10.39 | 12 | 99432 | 278 | 32413804 |
Withdrawal of life support | 20.02 | 10.39 | 6 | 99438 | 20 | 32414062 |
Pleuroperitoneal communication | 19.92 | 10.39 | 7 | 99437 | 43 | 32414039 |
Wrong product administered | 19.83 | 10.39 | 46 | 99398 | 4974 | 32409108 |
Dyskinesia | 19.65 | 10.39 | 26 | 99418 | 23577 | 32390505 |
Hospitalisation | 19.63 | 10.39 | 80 | 99364 | 48891 | 32365191 |
Respiratory tract infection bacterial | 19.51 | 10.39 | 16 | 99428 | 627 | 32413455 |
Cognitive disorder | 19.13 | 10.39 | 31 | 99413 | 25863 | 32388219 |
Hypernatraemia | 19.05 | 10.39 | 62 | 99382 | 8171 | 32405911 |
Foetal exposure during pregnancy | 18.82 | 10.39 | 64 | 99380 | 41237 | 32372845 |
Hepatotoxicity | 18.58 | 10.39 | 19 | 99425 | 19318 | 32394764 |
Psychotic disorder | 18.52 | 10.39 | 26 | 99418 | 22994 | 32391088 |
Peripheral vascular disorder | 18.35 | 10.39 | 46 | 99398 | 5226 | 32408856 |
Diabetic ulcer | 18.30 | 10.39 | 9 | 99435 | 140 | 32413942 |
Product prescribing error | 18.24 | 10.39 | 20 | 99424 | 19697 | 32394385 |
Urticaria | 17.80 | 10.39 | 108 | 99336 | 59506 | 32354576 |
Epilepsy | 17.75 | 10.39 | 25 | 99419 | 22084 | 32391998 |
Oropharyngeal pain | 17.63 | 10.39 | 44 | 99400 | 31308 | 32382774 |
Osteonecrosis | 17.54 | 10.39 | 15 | 99429 | 16607 | 32397475 |
Marasmus | 17.53 | 10.39 | 15 | 99429 | 624 | 32413458 |
Hallucination | 17.51 | 10.39 | 92 | 99352 | 52527 | 32361555 |
Neutropenia | 17.40 | 10.39 | 318 | 99126 | 141857 | 32272225 |
Tremor | 17.26 | 10.39 | 162 | 99282 | 81115 | 32332967 |
International normalised ratio increased | 17.09 | 10.39 | 227 | 99217 | 48808 | 32365274 |
Red blood cells urine positive | 16.99 | 10.39 | 24 | 99420 | 1762 | 32412320 |
Catheter site extravasation | 16.96 | 10.39 | 8 | 99436 | 113 | 32413969 |
Cardiomyopathy | 16.93 | 10.39 | 95 | 99349 | 15918 | 32398164 |
Sinusitis | 16.43 | 10.39 | 57 | 99387 | 36503 | 32377579 |
Diabetic vascular disorder | 16.23 | 10.39 | 7 | 99437 | 79 | 32414003 |
Cardiovascular insufficiency | 16.11 | 10.39 | 22 | 99422 | 1564 | 32412518 |
Rhabdomyolysis | 16.09 | 10.39 | 130 | 99314 | 67135 | 32346947 |
Metabolic alkalosis | 16.05 | 10.39 | 21 | 99423 | 1433 | 32412649 |
Extravasation | 15.82 | 10.39 | 24 | 99420 | 1879 | 32412203 |
Pruritus | 15.70 | 10.39 | 288 | 99156 | 128414 | 32285668 |
Dizziness | 15.69 | 10.39 | 505 | 98939 | 209113 | 32204969 |
Mood swings | 15.62 | 10.39 | 3 | 99441 | 8162 | 32405920 |
Oedema peripheral | 15.56 | 10.39 | 458 | 98986 | 113633 | 32300449 |
Atrial fibrillation | 15.51 | 10.39 | 467 | 98977 | 116237 | 32297845 |
Hepatocellular carcinoma | 15.48 | 10.39 | 6 | 99438 | 10264 | 32403818 |
Immune reconstitution inflammatory syndrome | 15.41 | 10.39 | 5 | 99439 | 9554 | 32404528 |
Depressed mood | 15.40 | 10.39 | 20 | 99424 | 18280 | 32395802 |
Withdrawal syndrome | 15.34 | 10.39 | 9 | 99435 | 12113 | 32401969 |
Vertigo | 15.34 | 10.39 | 32 | 99412 | 24251 | 32389831 |
Prescribed overdose | 15.31 | 10.39 | 5 | 99439 | 9514 | 32404568 |
Feeling abnormal | 15.28 | 10.39 | 115 | 99329 | 60308 | 32353774 |
Therapeutic product effect prolonged | 15.27 | 10.39 | 10 | 99434 | 275 | 32413807 |
Rash maculo-papular | 15.24 | 10.39 | 40 | 99404 | 27982 | 32386100 |
Bacterial translocation | 15.21 | 10.39 | 10 | 99434 | 277 | 32413805 |
Pneumococcal sepsis | 15.02 | 10.39 | 16 | 99428 | 877 | 32413205 |
Paraesthesia | 14.99 | 10.39 | 112 | 99332 | 58832 | 32355250 |
Generalised tonic-clonic seizure | 14.98 | 10.39 | 25 | 99419 | 20614 | 32393468 |
Scrotal swelling | 14.93 | 10.39 | 20 | 99424 | 1396 | 32412686 |
Visual acuity reduced | 14.86 | 10.39 | 17 | 99427 | 16428 | 32397654 |
Mental impairment | 14.85 | 10.39 | 6 | 99438 | 10006 | 32404076 |
Schizophrenia | 14.78 | 10.39 | 6 | 99438 | 9978 | 32404104 |
Dystonia | 14.75 | 10.39 | 7 | 99437 | 10616 | 32403466 |
Arthropathy | 14.75 | 10.39 | 29 | 99415 | 22460 | 32391622 |
Injection site bruising | 14.69 | 10.39 | 3 | 99441 | 7817 | 32406265 |
Pseudomonas test positive | 14.65 | 10.39 | 17 | 99427 | 1025 | 32413057 |
Bacteraemia | 14.47 | 10.39 | 98 | 99346 | 17535 | 32396547 |
Blood albumin decreased | 14.47 | 10.39 | 78 | 99366 | 12875 | 32401207 |
Product contamination microbial | 14.21 | 10.39 | 14 | 99430 | 699 | 32413383 |
Osteoarthritis | 14.20 | 10.39 | 24 | 99420 | 19695 | 32394387 |
Dyspnoea | 14.16 | 10.39 | 1288 | 98156 | 360757 | 32053325 |
Squamous cell carcinoma | 14.08 | 10.39 | 8 | 99436 | 10960 | 32403122 |
Sensory integrative dysfunction | 14.06 | 10.39 | 5 | 99439 | 32 | 32414050 |
Pain | 14.00 | 10.39 | 452 | 98992 | 187104 | 32226978 |
Emotional disorder of childhood | 13.93 | 10.39 | 5 | 99439 | 33 | 32414049 |
Mania | 13.92 | 10.39 | 6 | 99438 | 9626 | 32404456 |
Polyneuropathy | 13.85 | 10.39 | 12 | 99432 | 13203 | 32400879 |
Stress | 13.84 | 10.39 | 122 | 99322 | 23660 | 32390422 |
Arthritis | 13.84 | 10.39 | 39 | 99405 | 26653 | 32387429 |
Pathogen resistance | 13.62 | 10.39 | 6 | 99438 | 9504 | 32404578 |
Product container issue | 13.60 | 10.39 | 15 | 99429 | 855 | 32413227 |
Pneumocystis jirovecii pneumonia | 13.56 | 10.39 | 23 | 99421 | 18847 | 32395235 |
Leukopenia | 13.56 | 10.39 | 118 | 99326 | 60004 | 32354078 |
Intercepted medication error | 13.51 | 10.39 | 12 | 99432 | 525 | 32413557 |
Shoshin beriberi | 13.44 | 10.39 | 6 | 99438 | 74 | 32414008 |
Urinary tract infection | 13.36 | 10.39 | 330 | 99114 | 79741 | 32334341 |
Memory impairment | 13.34 | 10.39 | 71 | 99373 | 40408 | 32373674 |
Tendonitis | 13.34 | 10.39 | 5 | 99439 | 8730 | 32405352 |
Nosocomial infection | 13.32 | 10.39 | 18 | 99426 | 1267 | 32412815 |
Face oedema | 13.20 | 10.39 | 10 | 99434 | 11765 | 32402317 |
General physical health deterioration | 13.18 | 10.39 | 453 | 98991 | 114806 | 32299276 |
Blood glucose increased | 13.10 | 10.39 | 276 | 99168 | 64965 | 32349117 |
Abdominal discomfort | 13.08 | 10.39 | 230 | 99214 | 52394 | 32361688 |
Lymphadenopathy | 13.01 | 10.39 | 41 | 99403 | 27041 | 32387041 |
Postoperative wound infection | 13.00 | 10.39 | 38 | 99406 | 4726 | 32409356 |
Product storage error | 12.99 | 10.39 | 3 | 99441 | 7175 | 32406907 |
Blood pressure decreased | 12.96 | 10.39 | 224 | 99220 | 50856 | 32363226 |
Increased bronchial secretion | 12.96 | 10.39 | 21 | 99423 | 1740 | 32412342 |
Peritoneal perforation | 12.89 | 10.39 | 5 | 99439 | 42 | 32414040 |
Body temperature decreased | 12.81 | 10.39 | 9 | 99435 | 11005 | 32403077 |
Red blood cell sedimentation rate increased | 12.81 | 10.39 | 4 | 99440 | 7831 | 32406251 |
Irritability | 12.80 | 10.39 | 36 | 99408 | 24618 | 32389464 |
Infusion site necrosis | 12.78 | 10.39 | 4 | 99440 | 16 | 32414066 |
Glycosylated haemoglobin increased | 12.74 | 10.39 | 8 | 99436 | 10381 | 32403701 |
Erectile dysfunction | 12.65 | 10.39 | 26 | 99418 | 19813 | 32394269 |
Vocal cord paralysis | 12.58 | 10.39 | 15 | 99429 | 931 | 32413151 |
Bone marrow failure | 12.42 | 10.39 | 145 | 99299 | 30259 | 32383823 |
Obstructive airways disorder | 12.37 | 10.39 | 11 | 99433 | 11950 | 32402132 |
Hyperinsulinaemia | 12.34 | 10.39 | 6 | 99438 | 91 | 32413991 |
Gastric ischaemia | 12.31 | 10.39 | 3 | 99441 | 3 | 32414079 |
Mesenteric artery stenosis | 12.23 | 10.39 | 4 | 99440 | 19 | 32414063 |
Posthaemorrhagic hydrocephalus | 12.22 | 10.39 | 6 | 99438 | 93 | 32413989 |
Limb discomfort | 12.21 | 10.39 | 8 | 99436 | 10146 | 32403936 |
Post procedural complication | 12.16 | 10.39 | 70 | 99374 | 11837 | 32402245 |
Drug hypersensitivity | 12.10 | 10.39 | 155 | 99289 | 73245 | 32340837 |
Erythema | 12.09 | 10.39 | 180 | 99264 | 82925 | 32331157 |
Swelling of eyelid | 12.03 | 10.39 | 11 | 99433 | 500 | 32413582 |
Gamma-glutamyltransferase increased | 11.89 | 10.39 | 51 | 99393 | 30731 | 32383351 |
Lung consolidation | 11.89 | 10.39 | 40 | 99404 | 5363 | 32408719 |
Product preparation error | 11.87 | 10.39 | 21 | 99423 | 1869 | 32412213 |
Pleural effusion | 11.85 | 10.39 | 321 | 99123 | 78671 | 32335411 |
Device related sepsis | 11.83 | 10.39 | 25 | 99419 | 2538 | 32411544 |
Application site laceration | 11.75 | 10.39 | 4 | 99440 | 22 | 32414060 |
Drug withdrawal syndrome | 11.68 | 10.39 | 28 | 99416 | 20203 | 32393879 |
Toxic epidermal necrolysis | 11.66 | 10.39 | 105 | 99339 | 20488 | 32393594 |
Herpes zoster | 11.64 | 10.39 | 55 | 99389 | 32286 | 32381796 |
Hepatic enzyme increased | 11.64 | 10.39 | 66 | 99378 | 36971 | 32377111 |
Angina pectoris | 11.58 | 10.39 | 53 | 99391 | 31373 | 32382709 |
Panic attack | 11.54 | 10.39 | 7 | 99437 | 9254 | 32404828 |
Blood pressure increased | 11.50 | 10.39 | 172 | 99272 | 79182 | 32334900 |
Prostate cancer | 11.47 | 10.39 | 44 | 99400 | 27362 | 32386720 |
Haemoglobin decreased | 11.42 | 10.39 | 461 | 98983 | 119210 | 32294872 |
Septic shock | 11.41 | 10.39 | 284 | 99160 | 68705 | 32345377 |
Ileus | 11.38 | 10.39 | 87 | 99357 | 16178 | 32397904 |
Injection site erythema | 11.37 | 10.39 | 17 | 99427 | 14651 | 32399431 |
Delusion | 11.37 | 10.39 | 14 | 99430 | 13094 | 32400988 |
Pulmonary hypertension | 11.35 | 10.39 | 104 | 99340 | 20390 | 32393692 |
Acute respiratory failure | 11.29 | 10.39 | 136 | 99308 | 28592 | 32385490 |
Hyperinsulinaemic hypoglycaemia | 11.25 | 10.39 | 5 | 99439 | 61 | 32414021 |
Cellulitis | 11.25 | 10.39 | 216 | 99228 | 50014 | 32364068 |
Basal cell carcinoma | 11.22 | 10.39 | 23 | 99421 | 17545 | 32396537 |
Nasopharyngitis | 11.16 | 10.39 | 133 | 99311 | 63654 | 32350428 |
Hepatitis C | 11.14 | 10.39 | 15 | 99429 | 13503 | 32400579 |
Lymphocyte count decreased | 11.11 | 10.39 | 106 | 99338 | 21013 | 32393069 |
Anger | 11.09 | 10.39 | 12 | 99432 | 11892 | 32402190 |
Paranoia | 11.08 | 10.39 | 10 | 99434 | 10789 | 32403293 |
Dysarthria | 11.07 | 10.39 | 58 | 99386 | 33143 | 32380939 |
Photosensitivity reaction | 10.93 | 10.39 | 9 | 99435 | 10154 | 32403928 |
Injection site swelling | 10.93 | 10.39 | 8 | 99436 | 9576 | 32404506 |
Mucosal inflammation | 10.82 | 10.39 | 59 | 99385 | 33375 | 32380707 |
Blood creatine phosphokinase increased | 10.82 | 10.39 | 88 | 99356 | 45388 | 32368694 |
Renal tubular acidosis | 10.79 | 10.39 | 21 | 99423 | 2011 | 32412071 |
Atrial septal defect | 10.76 | 10.39 | 4 | 99440 | 7021 | 32407061 |
Mood altered | 10.73 | 10.39 | 7 | 99437 | 8897 | 32405185 |
Atelectasis | 10.72 | 10.39 | 88 | 99356 | 16720 | 32397362 |
Pneumoperitoneum | 10.71 | 10.39 | 20 | 99424 | 1856 | 32412226 |
Product contamination | 10.67 | 10.39 | 12 | 99432 | 699 | 32413383 |
Sexual dysfunction | 10.66 | 10.39 | 3 | 99441 | 6286 | 32407796 |
Incorrect drug administration rate | 10.66 | 10.39 | 16 | 99428 | 1241 | 32412841 |
Hydrocele | 10.63 | 10.39 | 22 | 99422 | 2202 | 32411880 |
Ventricular tachycardia | 10.49 | 10.39 | 122 | 99322 | 25434 | 32388648 |
Suprapubic pain | 10.44 | 10.39 | 9 | 99435 | 378 | 32413704 |
Injection site reaction | 10.41 | 10.39 | 12 | 99432 | 11557 | 32402525 |
Source | Code | Description |
---|---|---|
ATC | B05CX01 | BLOOD AND BLOOD FORMING ORGANS BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS IRRIGATING SOLUTIONS Other irrigating solutions |
ATC | C05BB56 | CARDIOVASCULAR SYSTEM VASOPROTECTIVES ANTIVARICOSE THERAPY Sclerosing agents for local injection |
ATC | V04CA02 | VARIOUS DIAGNOSTIC AGENTS OTHER DIAGNOSTIC AGENTS Tests for diabetes |
ATC | V06DC01 | VARIOUS GENERAL NUTRIENTS OTHER NUTRIENTS Carbohydrates |
CHEBI has role | CHEBI:75771 | Mus musculus metabolite |
CHEBI has role | CHEBI:75772 | bakers yeast metabolite |
CHEBI has role | CHEBI:76971 | E.coli metabolites |
CHEBI has role | CHEBI:77746 | H. sapiens metabolites |
MeSH PA | D005421 | Flavoring Agents |
MeSH PA | D005503 | Food Additives |
MeSH PA | D013549 | Sweetening Agents |
CHEBI has role | CHEBI:78675 | essential metabolite |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Hypoglycemia | indication | 302866003 | DOID:9993 |
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 11.87 | acidic |
pKa2 | 13.08 | acidic |
pKa3 | 13.91 | acidic |
None
None
None
ID | Source |
---|---|
4019541 | VUID |
N0000147647 | NUI |
D00009 | KEGG_DRUG |
77938-63-7 | SECONDARY_CAS_RN |
4017760 | VANDF |
4019541 | VANDF |
C0017725 | UMLSCUI |
CHEBI:4167 | CHEBI |
GLO | PDB_CHEM_ID |
CHEMBL1222250 | ChEMBL_ID |
CHEMBL1614854 | ChEMBL_ID |
D005947 | MESH_DESCRIPTOR_UI |
DB09341 | DRUGBANK_ID |
4536 | IUPHAR_LIGAND_ID |
LX22YL083G | UNII |
5793 | PUBCHEM_CID |
DB01914 | DRUGBANK_ID |
1299920 | RXNORM |
11133 | MMSL |
4567 | MMSL |
4787 | MMSL |
71873 | MMSL |
71874 | MMSL |
9763 | MMSL |
d00595 | MMSL |
000915 | NDDF |
002597 | NDDF |
111138002 | SNOMEDCT_US |
67079006 | SNOMEDCT_US |
725859007 | SNOMEDCT_US |
768547002 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0264-1290 | INJECTION, SOLUTION | 70 g | INTRAVENOUS | UNAPPROVED DRUG OTHER | 24 sections |
Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0264-1510 | INJECTION, SOLUTION | 50 mg | INTRAVENOUS | NDA | 24 sections |
MYOCARD-DX | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0264-1840 | INJECTION | 5 g | INTRAVENOUS | EXPORT ONLY | 20 sections |
MYOCARD-DX | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0264-1880 | INJECTION | 5 g | INTRAVENOUS | EXPORT ONLY | 20 sections |
Isolyte P in Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0264-7730 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 23 sections |
Dextrose in Lactated Ringers | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0264-7751 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 22 sections |
Theophylline in Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0264-9554 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 27 sections |
Heparin Sodium in Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0264-9567 | INJECTION | 5 g | INTRAVENOUS | NDA | 19 sections |
Heparin Sodium in Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0264-9577 | INJECTION | 5 g | INTRAVENOUS | NDA | 19 sections |
Heparin Sodium in Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0264-9587 | INJECTION | 5 g | INTRAVENOUS | NDA | 19 sections |
Lidocaine Hydrochloride and Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0264-9594 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 23 sections |
Lidocaine Hydrochloride and Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0264-9598 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 23 sections |
DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0338-0017 | INJECTION, SOLUTION | 50 g | INTRAVENOUS | NDA | 21 sections |
DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0338-0023 | INJECTION, SOLUTION | 100 g | INTRAVENOUS | NDA | 21 sections |
DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0338-0062 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0338-0066 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0338-0070 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
Dextrose and Sodium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0338-0073 | INJECTION, SOLUTION | 2.50 g | INTRAVENOUS | NDA | 21 sections |
DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0338-0074 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
Dextrose and Sodium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0338-0077 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0338-0078 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
Dextrose and Sodium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0338-0081 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0338-0082 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
Dextrose and Sodium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0338-0085 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
Dextrose and Sodium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 2 | 0338-0089 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
Lactated Ringers and Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 5 | 0338-0125 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 18 sections |
Dextrose and Electrolyte No. 48 | HUMAN PRESCRIPTION DRUG LABEL | 6 | 0338-0143 | INJECTION | 5 g | INTRAVENOUS | NDA | 19 sections |
Dextrose | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0338-0551 | INJECTION | 5 g | INTRAVENOUS | NDA | 21 sections |
Potassium Chloride in Dextrose and Sodium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 3 | 0338-0603 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |
Potassium Chloride in Dextrose and Sodium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 3 | 0338-0663 | INJECTION, SOLUTION | 5 g | INTRAVENOUS | NDA | 21 sections |